Tin tức & Cập nhật

Chỉ hiển thị Multimedia
Apixaban better than enoxaparin for extended-duration VTE prophylaxis after surgery

Apixaban better than enoxaparin for extended-duration VTE prophylaxis after surgery

29 Sep 2022 bởiStephen Padilla

Apixaban is not inferior to enoxaparin for extended-duration venous thromboembolic event (VTE) prophylaxis (EP) following urologic oncology surgery, reveals a study. In addition, apixaban is associated with fewer major complications and compliance-related adverse events.

Apixaban better than enoxaparin for extended-duration VTE prophylaxis after surgery

29 Sep 2022
Poverty a strong risk factor for obesity in kids

Poverty a strong risk factor for obesity in kids

29 Sep 2022
Plasma microRNAs disturbed in Alzheimer’s disease

Plasma microRNAs disturbed in Alzheimer’s disease

29 Sep 2022

Patients with Alzheimer’s disease (AD) show slightly dysregulated levels of plasma microRNAs (miRNA), including miRNA-92a-3p and miRNA-29a-3p, a recent study has found.

Plasma microRNAs disturbed in Alzheimer’s disease

29 Sep 2022
Telepsychiatry as reliable as face-to-face interviews for symptom assessment

Telepsychiatry as reliable as face-to-face interviews for symptom assessment

29 Sep 2022 bởiKanas Chan

Assessments of depressive, anxiety and psychotic symptoms and suicidal risk by telepsychiatry have good reliability in general when compared with face-to-face interviews, according to researchers from the Queen Mary Hospital (QMH).

Telepsychiatry as reliable as face-to-face interviews for symptom assessment

29 Sep 2022
Adjuvant pembrolizumab continues to improve DFS in clear cell RCC

Adjuvant pembrolizumab continues to improve DFS in clear cell RCC

28 Sep 2022 bởiRoshini Claire Anthony

In patients with clear cell renal cell carcinoma (RCC), adjuvant pembrolizumab continues to improve disease-free survival (DFS) over placebo, according to extended follow-up of the phase III KEYNOTE-564 trial.

Adjuvant pembrolizumab continues to improve DFS in clear cell RCC

28 Sep 2022